nodes	percent_of_prediction	percent_of_DWPC	metapath
Nandrolone phenpropionate—CYP19A1—Tryptophan metabolism—WARS—epilepsy syndrome	0.0314	0.0334	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—SNIP1—epilepsy syndrome	0.0306	0.0326	CbGpPWpGaD
Nandrolone phenpropionate—AR—Notch-mediated HES/HEY network—ASCL1—epilepsy syndrome	0.0272	0.0289	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nongenotropic Androgen signaling—GNAO1—epilepsy syndrome	0.0233	0.0248	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—SNTA1—epilepsy syndrome	0.0181	0.0193	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Endogenous sterols—CYP11A1—epilepsy syndrome	0.0179	0.0191	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CACNA1G—epilepsy syndrome	0.0151	0.0161	CbGpPWpGaD
Nandrolone phenpropionate—Norgestimate—ABCC2—epilepsy syndrome	0.0148	0.244	CrCbGaD
Nandrolone phenpropionate—CYP19A1—Tryptophan metabolism—UBE3A—epilepsy syndrome	0.0146	0.0156	CbGpPWpGaD
Nandrolone phenpropionate—AR—Coregulation of Androgen receptor activity—UBE3A—epilepsy syndrome	0.0135	0.0144	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of steroid hormones and vitamin D—CYP11A1—epilepsy syndrome	0.0134	0.0143	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nongenotropic Androgen signaling—PLCB1—epilepsy syndrome	0.0132	0.0141	CbGpPWpGaD
Nandrolone phenpropionate—AR—Coregulation of Androgen receptor activity—TCF4—epilepsy syndrome	0.0114	0.0121	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nongenotropic Androgen signaling—CDC42—epilepsy syndrome	0.0113	0.012	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metapathway biotransformation—KCNAB2—epilepsy syndrome	0.0108	0.0115	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—MECP2—epilepsy syndrome	0.0104	0.0111	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—ASCL1—epilepsy syndrome	0.0104	0.0111	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—FSH signaling pathway—BDNF—epilepsy syndrome	0.0103	0.011	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—UBE3A—epilepsy syndrome	0.01	0.0107	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—FLNA—epilepsy syndrome	0.00987	0.0105	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TCF4—epilepsy syndrome	0.00914	0.00973	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nuclear Receptors—VDR—epilepsy syndrome	0.00895	0.00953	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Ovarian Infertility Genes—VDR—epilepsy syndrome	0.00884	0.00941	CbGpPWpGaD
Nandrolone phenpropionate—AR—Coregulation of Androgen receptor activity—PTK2B—epilepsy syndrome	0.0086	0.00916	CbGpPWpGaD
Nandrolone phenpropionate—Testosterone—SLCO1A2—epilepsy syndrome	0.00845	0.139	CrCbGaD
Nandrolone phenpropionate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2C19—epilepsy syndrome	0.00836	0.0089	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP11A1—epilepsy syndrome	0.00831	0.00885	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—FSH signaling pathway—TSC2—epilepsy syndrome	0.00828	0.00882	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Oxidation by Cytochrome P450—CYP2C19—epilepsy syndrome	0.00825	0.00879	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Oxidation by Cytochrome P450—CYP11A1—epilepsy syndrome	0.0082	0.00873	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—RET—epilepsy syndrome	0.00809	0.00861	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nuclear Receptors—NR3C1—epilepsy syndrome	0.00806	0.00858	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Endogenous sterols—POMC—epilepsy syndrome	0.00792	0.00843	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—MAP2—epilepsy syndrome	0.00788	0.00839	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—NTF3—epilepsy syndrome	0.00752	0.00801	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2D6—epilepsy syndrome	0.0075	0.00799	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Oxidation by Cytochrome P450—CYP2D6—epilepsy syndrome	0.0074	0.00788	CbGpPWpGaD
Nandrolone phenpropionate—AR—Notch-mediated HES/HEY network—HES1—epilepsy syndrome	0.00739	0.00787	CbGpPWpGaD
Nandrolone phenpropionate—Testosterone—CYP11A1—epilepsy syndrome	0.00735	0.121	CrCbGaD
Nandrolone phenpropionate—AR—Nongenotropic Androgen signaling—FOS—epilepsy syndrome	0.00726	0.00772	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—GABRA1—epilepsy syndrome	0.00721	0.00767	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—SSTR1—epilepsy syndrome	0.00721	0.00767	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nuclear Receptor transcription pathway—VDR—epilepsy syndrome	0.00708	0.00753	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CAPN1—epilepsy syndrome	0.00707	0.00753	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of Androgen receptor activity—SIRT1—epilepsy syndrome	0.00696	0.00741	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—SSTR2—epilepsy syndrome	0.00694	0.00739	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Ovarian Infertility Genes—ATM—epilepsy syndrome	0.00681	0.00725	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Tryptophan metabolism—CAT—epilepsy syndrome	0.00681	0.00725	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	0.00678	0.00722	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	0.00674	0.00717	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—CHRNA7—epilepsy syndrome	0.0067	0.00713	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nuclear Receptor transcription pathway—NR3C1—epilepsy syndrome	0.00637	0.00678	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of Androgen receptor activity—NR3C1—epilepsy syndrome	0.00618	0.00657	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	0.00608	0.00647	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of steroid hormones and vitamin D—POMC—epilepsy syndrome	0.00593	0.00631	CbGpPWpGaD
Nandrolone phenpropionate—AR—Notch-mediated HES/HEY network—KDR—epilepsy syndrome	0.00592	0.0063	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—AQP4—epilepsy syndrome	0.0057	0.00607	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—SLC1A3—epilepsy syndrome	0.0057	0.00607	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—FSH signaling pathway—MTOR—epilepsy syndrome	0.0056	0.00597	CbGpPWpGaD
Nandrolone phenpropionate—AR—FOXA1 transcription factor network—FOS—epilepsy syndrome	0.00548	0.00584	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—CHRM2—epilepsy syndrome	0.00536	0.0057	CbGpPWpGaD
Nandrolone phenpropionate—Norethindrone—CYP2C19—epilepsy syndrome	0.0051	0.0841	CrCbGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—VDR—epilepsy syndrome	0.00489	0.0052	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—CDC42—epilepsy syndrome	0.00484	0.00516	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—CHRNB2—epilepsy syndrome	0.00481	0.00512	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nongenotropic Androgen signaling—SRC—epilepsy syndrome	0.00467	0.00498	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—MEF2C—epilepsy syndrome	0.00462	0.00492	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—SIRT1—epilepsy syndrome	0.0046	0.0049	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—EIF2AK2—epilepsy syndrome	0.00456	0.00485	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—JUND—epilepsy syndrome	0.00456	0.00485	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—YWHAZ—epilepsy syndrome	0.00451	0.00481	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—FSH signaling pathway—SRC—epilepsy syndrome	0.00449	0.00478	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—NR3C1—epilepsy syndrome	0.0044	0.00468	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—CHRNA4—epilepsy syndrome	0.00437	0.00465	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	0.00419	0.00446	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	0.00419	0.00446	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—TSC1—epilepsy syndrome	0.00417	0.00444	CbGpPWpGaD
Nandrolone phenpropionate—AR—Coregulation of Androgen receptor activity—CASP8—epilepsy syndrome	0.00412	0.00439	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—SLC6A4—epilepsy syndrome	0.00406	0.00432	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—SST—epilepsy syndrome	0.00395	0.0042	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—NTRK2—epilepsy syndrome	0.00395	0.0042	CbGpPWpGaD
Nandrolone phenpropionate—AR—FOXA1 transcription factor network—JUN—epilepsy syndrome	0.00394	0.00419	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—IL1RN—epilepsy syndrome	0.00393	0.00419	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	0.00368	0.00391	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—TH—epilepsy syndrome	0.00362	0.00385	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—CYP2C19—epilepsy syndrome	0.0036	0.00383	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—TSC1—epilepsy syndrome	0.00359	0.00382	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—CYP11A1—epilepsy syndrome	0.00358	0.00381	CbGpPWpGaD
Nandrolone phenpropionate—Testosterone—ABCG2—epilepsy syndrome	0.00357	0.0589	CrCbGaD
Nandrolone phenpropionate—CYP19A1—Metapathway biotransformation—CYP2C19—epilepsy syndrome	0.00355	0.00378	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metapathway biotransformation—CYP11A1—epilepsy syndrome	0.00353	0.00376	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of Androgen receptor activity—JUN—epilepsy syndrome	0.00339	0.00361	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—FOS—epilepsy syndrome	0.00337	0.00358	CbGpPWpGaD
Nandrolone phenpropionate—Progesterone—NR3C1—epilepsy syndrome	0.00326	0.0537	CrCbGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—CYP2D6—epilepsy syndrome	0.00323	0.00344	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metapathway biotransformation—CYP2D6—epilepsy syndrome	0.00319	0.00339	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	0.00318	0.00338	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—CDC42—epilepsy syndrome	0.00317	0.00338	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—JUNB—epilepsy syndrome	0.0031	0.0033	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of Androgen receptor activity—SRC—epilepsy syndrome	0.00304	0.00324	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—SIRT1—epilepsy syndrome	0.00301	0.00321	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—AVP—epilepsy syndrome	0.00299	0.00319	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	0.00298	0.00317	CbGpPWpGaD
Nandrolone phenpropionate—Progesterone—CYP2C19—epilepsy syndrome	0.00297	0.049	CrCbGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—BDNF—epilepsy syndrome	0.00295	0.00314	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	0.00291	0.00309	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nongenotropic Androgen signaling—AKT1—epilepsy syndrome	0.0029	0.00309	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—HES1—epilepsy syndrome	0.00283	0.00301	CbGpPWpGaD
Nandrolone phenpropionate—Norethindrone—ALB—epilepsy syndrome	0.00283	0.0466	CrCbGaD
Nandrolone phenpropionate—Testosterone—CYP2C19—epilepsy syndrome	0.00281	0.0463	CrCbGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	0.0028	0.00298	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—FSH signaling pathway—AKT1—epilepsy syndrome	0.00279	0.00297	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—WARS—epilepsy syndrome	0.00279	0.00297	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—MEF2C—epilepsy syndrome	0.00274	0.00291	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—CDC42—epilepsy syndrome	0.00273	0.00291	CbGpPWpGaD
Nandrolone phenpropionate—Norethindrone—ABCB1—epilepsy syndrome	0.0027	0.0445	CrCbGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—YWHAZ—epilepsy syndrome	0.00265	0.00282	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—NGF—epilepsy syndrome	0.00262	0.00278	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—NR3C1—epilepsy syndrome	0.0026	0.00277	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—SIRT1—epilepsy syndrome	0.00259	0.00276	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—RELA—epilepsy syndrome	0.00256	0.00272	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	0.00254	0.0027	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—BDNF—epilepsy syndrome	0.00251	0.00267	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—SIRT1—epilepsy syndrome	0.0025	0.00266	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—HTR2A—epilepsy syndrome	0.00249	0.00265	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—ABCB1—epilepsy syndrome	0.00247	0.00262	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CA13—epilepsy syndrome	0.00246	0.00262	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—JUN—epilepsy syndrome	0.00244	0.0026	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—TSC2—epilepsy syndrome	0.00243	0.00259	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—JUN—epilepsy syndrome	0.00242	0.00257	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—epilepsy syndrome	0.00237	0.00253	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—ATM—epilepsy syndrome	0.00229	0.00244	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—JUN—epilepsy syndrome	0.00224	0.00239	CbGpPWpGaD
Nandrolone phenpropionate—Progesterone—CYP2D6—epilepsy syndrome	0.0022	0.0363	CrCbGaD
Nandrolone phenpropionate—AR—Gene Expression—QARS—epilepsy syndrome	0.00212	0.00225	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—TSC2—epilepsy syndrome	0.00209	0.00222	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—SRC—epilepsy syndrome	0.00201	0.00214	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—CASP8—epilepsy syndrome	0.002	0.00213	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	0.00198	0.00211	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—ATM—epilepsy syndrome	0.00197	0.0021	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—ATM—epilepsy syndrome	0.0019	0.00202	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—FAR1—epilepsy syndrome	0.00187	0.00199	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ADK—epilepsy syndrome	0.00187	0.00199	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—L2HGDH—epilepsy syndrome	0.00187	0.00199	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GLUD1—epilepsy syndrome	0.00187	0.00199	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CERS1—epilepsy syndrome	0.00187	0.00199	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PDXK—epilepsy syndrome	0.00187	0.00199	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—CASP8—epilepsy syndrome	0.00172	0.00183	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—BCL2—epilepsy syndrome	0.00171	0.00182	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GAMT—epilepsy syndrome	0.00171	0.00182	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—NHLRC1—epilepsy syndrome	0.00171	0.00182	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PNPO—epilepsy syndrome	0.00171	0.00182	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—EPM2A—epilepsy syndrome	0.00171	0.00182	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—EIF2B5—epilepsy syndrome	0.00169	0.0018	CbGpPWpGaD
Nandrolone phenpropionate—AR—Coregulation of Androgen receptor activity—AKT1—epilepsy syndrome	0.00169	0.0018	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	0.00166	0.00176	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—MTOR—epilepsy syndrome	0.00164	0.00175	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—QDPR—epilepsy syndrome	0.00159	0.00169	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CA4—epilepsy syndrome	0.00159	0.00169	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—POMC—epilepsy syndrome	0.00158	0.00168	CbGpPWpGaD
Nandrolone phenpropionate—Progesterone—ABCB1—epilepsy syndrome	0.00157	0.0259	CrCbGaD
Nandrolone phenpropionate—Testosterone—ALB—epilepsy syndrome	0.00156	0.0257	CrCbGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—JUNB—epilepsy syndrome	0.00154	0.00164	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—TFAM—epilepsy syndrome	0.00153	0.00163	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—CASP3—epilepsy syndrome	0.00151	0.00161	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	0.0015	0.00159	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—COX3—epilepsy syndrome	0.00149	0.00159	CbGpPWpGaD
Nandrolone phenpropionate—Testosterone—ABCB1—epilepsy syndrome	0.00149	0.0245	CrCbGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—IL1B—epilepsy syndrome	0.00148	0.00157	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—BCL2—epilepsy syndrome	0.00147	0.00157	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—CASP3—epilepsy syndrome	0.00147	0.00157	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—JUN—epilepsy syndrome	0.00147	0.00156	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—JUN—epilepsy syndrome	0.00143	0.00152	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	0.00142	0.00151	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—SLC6A8—epilepsy syndrome	0.00142	0.00151	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—KCNB1—epilepsy syndrome	0.00142	0.00151	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PFKL—epilepsy syndrome	0.00142	0.00151	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—SLCO1A2—epilepsy syndrome	0.00142	0.00151	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CACNA2D2—epilepsy syndrome	0.00142	0.00151	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—MTOR—epilepsy syndrome	0.00141	0.00151	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	0.00138	0.00147	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	0.00137	0.00146	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	0.00135	0.00144	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—epilepsy syndrome	0.00135	0.00143	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—SNRPE—epilepsy syndrome	0.00132	0.00141	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—CASP3—epilepsy syndrome	0.0013	0.00138	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—NEU1—epilepsy syndrome	0.00129	0.00138	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—UPB1—epilepsy syndrome	0.00129	0.00138	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ATIC—epilepsy syndrome	0.00129	0.00138	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—VEGFA—epilepsy syndrome	0.00128	0.00137	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—JUN—epilepsy syndrome	0.00126	0.00134	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	0.00125	0.00133	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—VEGFA—epilepsy syndrome	0.00125	0.00133	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—AKT1—epilepsy syndrome	0.00125	0.00133	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—HSD17B4—epilepsy syndrome	0.00125	0.00133	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—VDR—epilepsy syndrome	0.00122	0.0013	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	0.00122	0.0013	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GBE1—epilepsy syndrome	0.0012	0.00128	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PPP1R3C—epilepsy syndrome	0.0012	0.00128	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	0.00118	0.00125	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ASAH1—epilepsy syndrome	0.00113	0.0012	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—epilepsy syndrome	0.0011	0.00117	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—STXBP1—epilepsy syndrome	0.0011	0.00117	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—NR3C1—epilepsy syndrome	0.0011	0.00117	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	0.00109	0.00116	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—NT5E—epilepsy syndrome	0.00107	0.00114	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ALAD—epilepsy syndrome	0.00107	0.00114	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—TNF—epilepsy syndrome	0.00107	0.00114	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	0.00106	0.00113	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CACNA1A—epilepsy syndrome	0.00102	0.00109	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ALDH7A1—epilepsy syndrome	0.00102	0.00109	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ST3GAL3—epilepsy syndrome	0.001	0.00107	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ADSL—epilepsy syndrome	0.000981	0.00104	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GLUL—epilepsy syndrome	0.000962	0.00102	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CACNA1D—epilepsy syndrome	0.000944	0.00101	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—EIF2S1—epilepsy syndrome	0.000921	0.00098	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	0.000911	0.00097	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—HSPB1—epilepsy syndrome	0.000888	0.000946	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—TXNRD1—epilepsy syndrome	0.000883	0.00094	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—AQP1—epilepsy syndrome	0.000857	0.000913	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	0.000823	0.000877	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—AKT1—epilepsy syndrome	0.000818	0.000871	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—KCNJ11—epilepsy syndrome	0.000775	0.000825	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CHRM3—epilepsy syndrome	0.000775	0.000825	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—JUNB—epilepsy syndrome	0.000741	0.000789	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	0.000722	0.000769	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	0.000708	0.000753	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—AKT1—epilepsy syndrome	0.000704	0.00075	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	0.000678	0.000722	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ABCG2—epilepsy syndrome	0.000632	0.000673	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CYP2C19—epilepsy syndrome	0.000616	0.000656	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CYP11A1—epilepsy syndrome	0.000612	0.000652	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	0.000608	0.000647	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—SIRT1—epilepsy syndrome	0.000597	0.000636	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—VDR—epilepsy syndrome	0.000588	0.000626	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—H2AFX—epilepsy syndrome	0.000558	0.000594	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	0.000554	0.00059	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CYP2D6—epilepsy syndrome	0.000552	0.000588	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—YWHAZ—epilepsy syndrome	0.000538	0.000573	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—NR3C1—epilepsy syndrome	0.00053	0.000564	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ADRA2A—epilepsy syndrome	0.000526	0.00056	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—BCHE—epilepsy syndrome	0.000524	0.000558	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—SLC2A1—epilepsy syndrome	0.0005	0.000532	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PLCB1—epilepsy syndrome	0.000494	0.000526	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—TH—epilepsy syndrome	0.000492	0.000524	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	0.000485	0.000516	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—HMOX1—epilepsy syndrome	0.000411	0.000438	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CAT—epilepsy syndrome	0.000406	0.000432	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ABCB1—epilepsy syndrome	0.000394	0.00042	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GPX1—epilepsy syndrome	0.000367	0.00039	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—AGT—epilepsy syndrome	0.000322	0.000342	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—APOE—epilepsy syndrome	0.000315	0.000335	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—POMC—epilepsy syndrome	0.000271	0.000288	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ALB—epilepsy syndrome	0.000247	0.000263	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PTGS2—epilepsy syndrome	0.000216	0.00023	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—AKT1—epilepsy syndrome	0.000162	0.000173	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—AKT1—epilepsy syndrome	0.000109	0.000116	CbGpPWpGaD
